Insulin-like growth factor-I deficiency caused by a partial deletion of the IGF-I gene: effects of rhIGF-I therapy (Q33767038)

29 July 2017

Insulin-like growth factor-I deficiency caused by a partial deletion of the IGF-I gene: effects of rhIGF-I therapy (English)

1 reference

29 July 2017

5

Savage MO

1 reference

29 July 2017

Cecilia Camacho-Hübner

series ordinal

1

object named as

Camacho-Hübner C

1 reference

29 July 2017

Woods KA

2

1 reference

29 July 2017

Miraki-Moud F

series ordinal

3

1 reference

29 July 2017

Clark A

series ordinal

4

1 reference

29 July 2017

language of work or name

1 reference

1 June 1999

1 reference

Growth Hormone & I G F Research

29 July 2017

1 reference

29 July 2017

9 Suppl B

1 reference

29 July 2017

47-51; discussion 51-2

1 reference

Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

Role of insulin-like growth factors in embryonic and postnatal growth

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

IGF-I is required for normal embryonic growth in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

Laron syndrome: clinical features, molecular pathology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

Insulin-like growth factor I gene deletion causing intrauterine growth retardation and severe short stature.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

Variations in the Pattern of Pubertal Changes in Boys

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

A monoclonal antibody to human insulin-like growth factor-I: characterization, use in radioimmunoassay and effect on the biological activities of the growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

Nicotinamide and insulin secretion in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

The modified minimal model: application to measurement of insulin sensitivity in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

The effects of recombinant insulin-like growth factor I administration on growth hormone levels and insulin requirements in adolescents with Type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

Growth hormone insensitivity syndromes: a preliminary report on changes in insulin-like growth factors and their binding proteins during treatment with recombinant insulin-like growth factor I. Kabi Pharmacia Study Group on Insulin-like Growth Facto

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

Pharmacokinetics of recombinant human insulin-like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

The physiology and pathophysiology of intrauterine growth retardation

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2899%2980081-1

7 January 2021

10.1016/S1096-6374(99)80081-1

Identifiers

DOI

1 reference

29 July 2017

1 reference